APPLICATIONS PUBLISHED 30 OCTOBER 2002
Published: 1-Apr-2003
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
Diclofenamide suspension gel
Dr Gerhard Mann 1251826*
Nasally administrable cyclic peptide compsns
Basilea Pharmaceutica 1251827*
Local drug delivery using photosensitiser-mediated and electromagnetic radiation-enhanced vascular permeability
Miravant Medical Technologies 1251828*
Electrospun pharmaceutical compsns
SmithKline Beecham 1251829*
Continuous method for preparing pharmaceutical granules
Rhodia Chemie 1251830*
Pharmaceutical compsns comprising a HMG CoA reductase inhibitor
AstraZeneca 1251831*
Shell-and-core dosage form approaching zero-order drug release
DepoMed 1251832*
Gellan gum dipped products
Monsanto 1251833*
Reduced form of coenzyme Q in high bioavailability stable dosage forms and related applications
Chopra, Raj 1251834*
Closure of bacterial ghosts
Lubitz, Werner 1251835*
Use of BVDU for inhibiting the growth of hyperproliferative cells
NewBiotics 1251836*
Compounds and methods for modulating cerebral amyloid angiopathy
Neurochem 1251837*
Method for using potassium channel agonists for delivering a medicament to an abnormal brain region and/or a malignant tumour
Cedars-Sinai Medical Center 1251838*
Use of COX-2 inhibitors for the treatment of constipation
Glaxo Group 1251839*
Method using potassium channel activation for delivering a medicant to an abnormal brain region and/or a malignant tumour
Cedars-Sinai Medical Center 1251840*
Aqueous solution for treating degenerative or autoimmune diseases and as immunomodulatory agent
Naessens, Gaston 1251841*
Use of modafinil for making a medicine for correcting disorders affecting vigilance related to myopathies
Laboratoire L Lafon 1251842*
Compsns for delivery of a cortisonal antagonist
Cortendo; Gardner, Rebecca 1251843*
Laxative preparation containing L-arginine
Norgine Research; President and Fellows of Harvard College 1251844*
Purifying polyoxyethylated castor oils with activated charcoal and pharmaceutical formulations thereof
Baker Norton Pharmaceuticals 1251845*
C-4 carbonate taxanes
Bristol-Myers Squibb 1251846*
Novel use of prodigiosin for treating diabetes mellitus
Korea Research Institute for Bioscience and Biotechnology 1251847*
Gyrase inhibitors and uses thereof
Vertex Pharmaceuticals 1251848*
Combination therapy for cancer
Schering 1251850*
Treating allergic and inflammatory conditions
Schering 1251851*
Use of desloratidine for treating allergic and inflammatory conditions
Schering 1251852*
Transdermal therapeutic system
LTS Lohmann Therapie-Systeme 1251853*
Drug combination for the treatment of depression and related disorders comprising mirtazapine and gepirone
Akzo Nobel 1251854*
Selective estrogen receptor modulators in combination with estrogens
Endorecherche 1251855*
Method of increasing alertness by administration of a vomeropherin, and vomerpherin-releasing alarm devices
Pherin Pharmaceuticals 1251856*
Pharmaceutical parenteral compsn containing a bisphosphonate
F Hoffmann-La Roche 1251857*
Podophyllotoxin compsns
Supratex Pharma 1251858*
Novel compounds
Xylogen 1251859*
Somnogenic activity of non-pathogenic lactic acid bacteria
Compagnie Gervais Danone 1251860*
Physiologically active compsns of Basidomycotina and Araliaceae extracts
Goino, Tadashi 1251861*
Ophthalmic compsns for treating ocular hypertension
Merck 1251862*
22 secreted human proteins
Human Genome Sciences 1251863*
Pharmaceutical formulation composed of a polymer blend and an active compound for time-controlled release
Rutgers, the State University 1251864*
Cyclic peptides as potent and selective melanocortin-4 receptor antagonists
Merck 1251865*
Combination of temozolomide and pegylated interferon-alpha for treating cancer
Schering 1251866*
Nasal calcitonin formulations
Unigene Laboratories 1251867*
Combination therapy for the treatment of inflammatory and respiratory diseases
Eli Lilly 1251868*
Compsns and method for preventing reactogenicity associated with administration of immunogenic live rotavirus compsns
The Government of the United States of America, as represented by the Department of Health and Human Services 1251869*
Novel use
SmithKline Beecham 1251870*
Pharmaceutical compsn for immunomodulation and preparation of vaccines comprising an antigen and an immunogenic oligodeoxynucleotide and a polycationic polymer as adjuvants
Cisterm Biotechnologies 1251871*
Compsns and methods for treating cell proliferation disorders
Schering 1251872*
Antagonist of TH-1 immune response inducing cytokine for the treatment of autoimmune diseases
Pharma Pacific 1251873*
Stabilised pharmaceutical compsns and processes for their preparation comprising an antibiotic and an expectorant
New Pharma Research Sweden 1251874*
Use of contrast agents in the manufacture of diagnostic agent for the visualisation of the intestinal lumen
Bracco Imaging 1251875*
Magnetic resonance imaging using contrast agents prodrugs bioactivated by enzyme cleavage
Epix Medical 1251876*
Site specific binding system, nuclear imaging compsns and methods
Barnes-Jewish Hospital 1251877*
Palatable arginine compounds and uses thereof for cardiovascular health
Procter & Gamble 1252137*
A new process for the preparation of latanoprost
Finetech Laboratories 1252138*
Tosylproline analogues as thymidylate synthase inhibitors
Sunesis Pharmaceuticals 1252141*
Indole derivatives as MCP-1 receptor antagonists
AstraZeneca 1252142*
Method for preparing alpha-sulphonyl hydroxamic acid derivatives
American Cyanamid 1252143*
Substituted glutarimides and use thereof IL-12 production inhibitors
Gruenenthal 1252144*
Antipicornaviral compounds and composites, their pharmaceutical uses, and materials for their synthesis
Agouron Pharmaceuticals 1252145*
Amide compounds for inhibiting protein kinases
Agouron Pharmaceuticals 1252146*
Bloom-resistant benzotriazole UV absorbers and compsns stabilised therewith
Ciba Specialty Chemicals Holding 1252147*
Novel heterocyclic derivatives, preparation method and pharmaceutical compsns containing same
Les Laboratoires Servier 1252150*
A process for the preparation of quetiapine and intermediates therefor
Egis Gyogyszergyar 1252151*
Urea compounds as inhibitors for VLA-4
AstraZeneca 1252152*
Substituted piperidines, medicaments containing these compounds and methods for the production thereof
Boehringer Ingelheim Pharma 1252153*
Heterocyclic amide derivatives
Pfizer Products 1252154*
Ethanol solvate of (-)-cis-2-(2-chlorophenyl)-5,7-dihydroxy-8 4R-(3S-hydroxy-1-methyl)piperidinyl]-4H-1-benzopyran-4-one
Aventis Pharmaceuticals 1252155*
Blockage of voltage dependent sodium channels
University College London 1252156*
Pyrimidine carboxamides useful as inhibitors of PDE4 isozymes
Pfizer Products 1252157*
Nictotinamide benzofused-heterocyclyl derivatives useful as selective inhibitors of PDE4 isozymes
Pfizer Products 1252158*
Method for producing heterocyclic compounds
Bayer 1252159*
